M7 Healthcare Investment Conference | International Roadshow Pitch

560 Mission Street,San Francisco CA 94105

09 January, 2023

Description

M7 Healthcare Accelerator and eChinaHealth will be co-hosting a Healthcare Investment Conference during the J.P. Morgan 41st Annual Healthcare Conference on January 9th, 2023. M7 Healthcare Accelerator aims to bring global innovators together during this two-part event by offering back-to-back conferences, an evening reception, and a healthcare startup roadshow. The evening International Roadshow Pitch will also be featured simultaneously at multiple venues nationwide, including China, Germany, and France. Livestream will be available for individuals who cannot make it to the venues. For startups who want to pitch at the evening International Roadshow, please apply here: https://forms.gle/hBJxQivz1mutKdyBA Agenda:Morning Conference: Investment Trend in Digital Health & Precision Medicine Location: J.P. Morgan Private Bank Client Center Address: 560 Mission Street, 23rd Floor, San Francisco, CA 94105 9:30-10:00 AM: Registration 10:00 - 10:05 AM: Opening Remark Ella Li, Ph.D.: Founder & CEO, M7 AcceleratorChristina Lee: Vice President, Global Families Group Asia Team at J.P. Morgan Private Bank10:05 - 10:35 AM: Fireside Chat - How Artificial Intelligence is Powering Healthcare Innovation Prasun Mishra, Ph.D.: Founding President & CEO, American Association for Precision MedicineAtul Butte, Ph.D.: Director, Bakar Computational Health Sciences Institute10:35-11:10 AM: Panel I — Trends in digital health investment in 2023 Ella Li, Ph.D.: Founder & CEO, M7 AcceleratorDarwin Ling: Founder & General Partner, Good AI CapitalGopi Rangan, Ph.D.: Founding Partner, Sure Ventures Jordan Wahbeh: Managing Partner, SV Venture Group/Network.VC11:10-11:50 AM: Panel II — Precision Medicine: The next frontier in healthcare investing Prasun Mishra, Ph.D.: Founding President & CEO, American Association for Precision MedicineFaye K. Sahai: Managing Partner, Telosity VentureNishit Doshi, Ph.D: Director of Product Management, RocheShannon Muir, Ph.D: Co-Director, California Initiative to Advance Precision MedicineInternational Roadshow Pitch | China Night Reception Location: The Historic Klamath Ferry Address: Pier 9, The Embarcadero, San Francisco, CA 94111 6:30-7:30 PM: Roadshow Pitch 7:30-9:00 PM: China Night Reception Global Satellite Venues for Evening Roadshow:Located in Beijing, Zhongguancun (ZGC) Life Science Park is home to more than 500 research institutions and companies focused on R&D in life sciences, biotechnology, and biomedicine. Authorized by the Beijing Municipal Government, ZGC Life Science Park plays an important role in the growth and expansion of Beijing’s science-based businesses and has helped researchers take their work from basic research all the way to clinical application. ZGC is committed to incubating promising startups and building an international-level first-class science and technology park. Located in Beijing, China, Beijing Daxing International Airport Economic Zone ((BDIA Economic Zone) is strategically positioned as an area for international exchange, a leading area for national aviation technology innovation, and a demonstration area for coordinated development of Beijing, Tianjin, and Hebei. BDIA Economic Zone aims to build up a “1+2+2” industrial system, consisting of 1 leading industry of Life & Health, 2 basic key industries of High-End Hub Services and Aviation Support Services, and 2 industries of the future–Next Generation IT and Intelligent Equipment. Located in Lyon, France, Association d’Incubateur Franco-Chinois (AIFC) was established to respond to promote business cooperation and advanced technology exchanges between Chinese and European Enterprises. AIFC is a two-way service platform for French and Chinese entrepreneurship and innovation projects and provides consulting, incubation services, cooperation activities, exchange forums, and resource integration for projects with European backgrounds. AIFC invests in promotions of high-quality projects and puts implementation first, building bridges between enterprises and governments. Located in Berlin, Germany, Huizhong Industry Service Center (Huizhong) aims to create a platform for promoting economic and trade exchanges between China and Germany by introducing advanced German technologies and experiences to China.` Acting as an investment promoter, an information platform, an overseas contact point, and a competition organizer, Huizhong provides full-stack support of funding, marketing opportunities, and joint ventures in China. Huizhong makes every attempt to fully use its information advantages in overseas science and technology, culture, talent, and projects as well as the industry advantages in the development zones, investment institutions, business environment, and support services. Organizers:Headquartered in Silicon Valley, the M7 Healthcare Accelerator is a healthcare innovation platform and a catalyst that provides a series of commercialization services to grow startups all over the world—a unique opportunity for entrepreneurs to build, launch and scale their big healthcare idea. M7's mission is to link the outstanding global healthcare startups with investors, mentors and corporate partners, and together to build a resource-rich healthcare innovation ecosystem. M7 is focusing on the early-stage Biotech, MedTech and Device startups and have designed a 3-month acceleration program to fund and mentor young leaders creating the solutions for a sustainable and accessible healthcare future. During the program, M7 offers mentorship, training workshops, funding and networking opportunities, global business partnerships, and workspace in Silicon Valley to support startups. eChinaHealth is an independent medical education company and has offices in San Francisco, Shanghai, and Qingdao. eChinaHealth provides integrated media, conferences & events, and medical education services in China healthcare and pharmaceutical segments. Healthcare media: “eChinaHealth News” provides timely and professional international healthcare and medical news to Chinese doctors, in a varieties of new media formats including WeChat News, Newsletter, Video, etc. The global healthcare news contents are provided by the MJH Media Group. Conferences and Events: eChinaHealth is officially authorized by the American Society of Clinical Oncology (ASCO) to organize “ASCO Direct China” conferences; and by the American Society of Endocrinology (ES) to organize “ENDO Direct China” conferences, in an effort to provide Chinese doctors’ access to the most cutting-edge research discussed at global healthcare meetings. eChinaHealth also organizes China-focus conference/dinner/receptions during major global healthcare conferences. Medical Education and Training: eChinaHealth collaborates with global medical education organizations to provide global educational workshops, academic exchanges, and physician trainings to Chinese doctors and healthcare professionals. Novotech is a leading full-service clinical contract research organization (CRO) with integrated labs, phase I facilities, SMO, and drug development consulting services. Embedded in Asia, it has accumulated extensive experience in over 3,700 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies across broad therapeutic areas. With over 2700 employees working across our offices in 14 geographies in Asia-Pacific, North America, Europe, and South Africa, Novotech is well positioned to provide high-quality clinical study services for biopharmaceutical clients in Asia Pacific and globally. With over 5000 customer-centric employees, operations and commercial offices across the US, EU and China, Porton Pharma Solutions provides global pharmaceutical companies with innovative, reliable and end-to-end process R&D and manufacturing services across small molecule APIs, dosage forms and biologics. Porton's Process Technology Centers and WHO/USFDA/EMA/PDMA/NMPA-inspected Manufacturing Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets, plus over 1400 highly skilled scientists and process engineers, all backed by proven program management system dedicated to seamlessly delivering successful outcomes for unique project requirements. Porton is committed to being the most open, innovative and reliable pharmaceutical service platform in the world and enabling public early access to good medicines. We constantly strive for excellence and have been recognized through awards by industry forums and global pharmaceutical companies for our process innovation, supply chain performance and compliance with global Quality and EHS standards. By efficiently advancing development and enabling commercialization of multiple high-impact medicines, Porton is proud to have earned the trust of some of the world’s leading and most innovative pharmaceutical companies and many biotechnology companies across the US, EU, and Asia.